Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis

A technology of chronic rhinitis and magnolia, applied in the field of traditional Chinese medicine, can solve problems such as treating the symptoms but not the root cause, and achieve the effect of improving the internal environment, with few side effects and low cost

CN102793747AInactive Publication Date: 2012-11-28张艳忠
0 Cites 10 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2012-11-28
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention discloses Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis. The Chinese medicinal magnolia flower and angelica dahurica powder comprises the following Chinese medicinal components in part by weight: 14 to 16 parts of magnolia flower, 29 to 31 parts of angelica dahurica, 14 to 16 parts of mint and 6 to 8 parts of siberian cocklour fruit (fried). The common pure Chinese medicines are taken as components, and are reasonably compatible; the Chinese medicinal magnolia flower and angelica dahurica powder does not have toxic or side effects, and is convenient to use; and when the powder is orally taken, an optimal effect can be achieved.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to Xinyi Baizhi Powder, a traditional Chinese medicine for treating chronic rhinitis. Background technique

[0002] Chronic rhinitis refers to the non-specific inflammation of the nasal mucosa and submucosa that lasts for more than several months, or the inflammation recurs, and the submucosa cannot return to normal during the interval period. Clinically, it is characterized by persistent or intermittent, alternating nasal congestion and increased nasal mucus. The primary disease is mostly caused by incomplete development and evolution of acute rhinitis treatment. Clinically divided into chronic simple rhinitis and chronic hypertrophic rhinitis. Its clinical manifestations are:

[0003] Chronic simple rhinitis:

[0004] Nasal congestion is intermittent or alternating, and generally relieves or disappears during the day and after activities; at night, when s...

Examples

Embodiment 1

[0026] The traditional Chinese medicine Xinyi powder of the present invention comprises the following traditional Chinese medicine components in weight ratio: 14 parts of Xinyi, 29 parts of Angelica dahurica, 14 parts of peppermint, and 6 parts of cocklebur (stir-fried). Grind the traditional Chinese medicines in the above proportions into fine powder.

Embodiment 2

[0028] The traditional Chinese medicine Xinyi powder of the present invention comprises the following traditional Chinese medicine components in weight ratio: 15 parts of Xin Yi, 30 parts of Angelica dahurica, 15 parts of peppermint, and 7 parts of cocklebur (stir-fried). Grind the traditional Chinese medicines in the above proportions into fine powder.

Embodiment 3

[0030] The traditional Chinese medicine Xinyi powder of the present invention comprises the following traditional Chinese medicine components in weight ratio: 15 parts of Xinyi, 30 parts of Angelica dahurica, 15 parts of mint, and 6 parts of cocklebur (stir-fried). Grind the traditional Chinese medicines in the above proportions into fine powder.